Lv21
160 积分 2025-06-05 加入
Navigating the complexities of drug development for inflammatory bowel disease
14天前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
1个月前
已完结
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
1个月前
已完结
Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model
1个月前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
1个月前
已完结
Session 5: Protein Degraders
1个月前
已完结
皖公网安备34019202002308
